Data on Chikungunya Virus Detailed by Researchers at Stanford University (Chikungunya Virus Virus-like Particle Vaccine Is Well Tolerated and Immunogenic In Chikungunya Seropositive Individuals)

Press/Media

PeriodNov 27 2023

Media coverage

1

Media coverage

  • TitleData on Chikungunya Virus Detailed by Researchers at Stanford University (Chikungunya Virus Virus-like Particle Vaccine Is Well Tolerated and Immunogenic In Chikungunya Seropositive Individuals)
    Media name/outletVaccine Daily
    Country/TerritoryUnited States
    Date11/27/23
    PersonsLu Chen
View all 1
View less